Italian Platelet Technology Assessment Study (IPTAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01642563
Recruitment Status : Terminated (Patient enrolment below planned schedule)
First Posted : July 17, 2012
Last Update Posted : July 28, 2015
Cerus Corporation
Terumo BCT
Information provided by (Responsible Party):
Centro Nazionale Sangue

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : March 2015
Rebulla P, Grazzini G, Liumbruno GM, Aprili G, Formisano S, Girelli G, Marconi M, Salvaneschi L, Strada P, Zolla L. Pathogen inactivated platelets and prevention of immunological adverse reactions: the Italian Platelet Technology Assessment Study (IPTAS). Blood Transfus 2009;7 Suppl 1:s19-s21. DOI 10.2450/2009.0013-09.